Scott Gottlieb, M.D. discusses the unanticipated problems and costs from the health care bill that are now emerging for the pharmaceutical industry

Scott Gottlieb, M.D., a practicing physician and a resident fellow at the American Enterprise Institute discusses the unanticipated problems and costs from the health care bill that are now emerging for the pharmaceutical industry.